Iron deficiency anemia in women across the life span

Journal of Women's Health

Volumn 21, Issue 12, 2012, Pages 1282-1289

  Friedman, Arnold J ^a   Chen, Zhao ^b   Ford, Patricia ^c   Johnson, Cynda Ann ^d   Lopez, Ana Maria ^e   Shander, Aryeh ^f   Waters, Jonathan H ^g   Van Wyck, David ^h  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERRLICIT; FERUMOXYTOL; IRON; IRON DEXTRAN; IRON SACCHARATE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; CHRONIC DISEASE; CLIMACTERIUM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON THERAPY; LIFESPAN; MORBIDITY; MORTALITY; POSTMENOPAUSE; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; QUALITY OF LIFE; RISK FACTOR; SHORT FORM 36; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; WELLBEING;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HUMANS; IRON; MENOPAUSE; MIDDLE AGED; POSTPARTUM PERIOD; PREGNANCY; QUALITY OF LIFE; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84870806031     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3713     Document Type: Article

References (79)

1. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009;12:444-454.
2. Cusick SE, Mei Z, Freedman DS, et al. Unexplained decline in the prevalence of anemia among US children and women between 1988-1994 and 1999-2002. Am J Clin Nutr 2008; 88:1611-1617.
3. Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: Anaemia or transfusion? Br J Anaesth 2011;107 (Suppl 1):i41-i59.
4. Deal JA, Carlson MC, Xue QL, Fried LP, Chaves PH. Anemia and 9-year domain-specific cognitive decline in communitydwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc 2009;57:1604-1611.
5. Carter RC, Jacobson JL, Burden MJ, et al. Iron deficiency anemia and cognitive function in infancy. Pediatrics 2010; 126:e427-e434.
6. Wilson C, Brothers M. Iron deficiency in women and its potential impact on military effectiveness. Nurs Clin North Am 2010;45:95-108.
7. Hernandez-Martinez C, Canals J, Aranda N, Ribot B, Escribano J, Arija V. Effects of iron deficiency on neonatal behavior at different stages of pregnancy. Early Hum Dev 2011;87:165-169.
8. McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr 2007;85:931-945.
9. Perez EM, Hendricks MK, Beard JL, et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. J Nutr 2005;135:850-855.
10. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. Am J Clin Nutr 2009;89:946S-950S.
11. Beard JL, Hendricks MK, Perez EM, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 2005;135:267-272.
12. Ando K, Morita S, Higashi T, et al. Health-related quality of life among Japanese women with iron-deficiency anemia. Qual Life Res 2006;15:1559-1563.
13. Ballin A, Berar M, Rubinstein U, Kleter Y, Hershkovitz A, Meytes D. Iron state in female adolescents. Am J Dis Child 1992;146:803-805.
14. Patterson AJ, Brown WJ, Roberts DC. Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr 2001;20:337-342.
15. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-377.
16. Rose EA, Porcerelli JH, Neale AV. Pica: Common but commonly missed. J Am Board Fam Pract 2000;13:353-358.
17. Lukaski HC, Hall CB, Nielsen FH. Thermogenesis and thermoregulatory function of iron-deficient women without anemia. Aviat Space Environ Med 1990;61:913-920.
18. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 2011;17:899-906.
19. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE, Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996;7:763-773.
20. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis 2005;45:658-666.
21. Jones M, Schenkel B, Just J, Fallowfield L. Epoetin alfa improves quality of life in patients with cancer: Results of meta-analysis. Cancer 2004;101:1720-1732.
22. Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc 2007;82:1244-1254.
23. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 2001;107:1381-1386.
24. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: An analysis of risk factors. South Med J 2005;98:419-422.
25. Nicol B, Croughan-Minihane M, Kilpatrick SJ. Lack of value of routine postpartum hematocrit determination after vaginal delivery. Obstet Gynecol 1997;90:514-518.
26. Prendiville WJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: Active versus physiological management of third stage of labour. BMJ 1988;297:1295-1300.
27. Recommendations to prevent and control iron deficiency in the United States. MMWR 1998;47 (RR-3):1-29.
28. Fomon SJ, Drulis JM, Nelson SE, Serfass RE, Woodhead JC, Ziegler EE. Inevitable iron loss by human adolescents, with calculations of the requirement for absorbed iron. J Nutr 2003;133:167-172.
29. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996;348:992-996.
30. Devaki PB, Chandra RK, Geisser P. Effects of oral iron (III) hydroxide polymaltose complex supplementation on hemoglobin increase, cognitive function, affective behavior and scholastic performance of adolescents with varying iron status: A single centre prospective placebo controlled study. Arzneimittelforschung 2009;59:303-310.
31. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007; 85:778-787.
32. Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cognition in older children and adults: A systematic review and meta-analysis. Nutr J 2010;9:4.
33. Nelson M, Bakaliou F, Trivedi A. Iron-deficiency anaemia and physical performance in adolescent girls from different ethnic backgrounds. Br J Nutr 1994;72:427-433.
34. Nelson M. Anaemia in adolescent girls: Effects on cognitive function and activity. Proc Nutr Soc 1996;55:359-367.
35. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann NY Acad Sci 2000;900:125-136.
36. Routine iron supplementation during pregnancy. Review article. U.S. Preventive Services Task Force. JAMA 1993;270: 2848-2854.
37. Routine iron supplementation during pregnancy. Policy statement. US Preventive Services Task Force. JAMA 1993; 270:2846-2848.
38. Lund CJ. Studies on the iron deficiency anemia of pregnancy; including plasma volume, total hemoglobin, erythrocyte protoporphyrin in treated and untreated normal and anemic patients. Am J Obstet Gynecol 1951;62:947-963.
39. Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005;60:663-671.
40. Bodnar LM, Scanlon KS, Freedman DS, Siega-Riz AM, Cogswell ME. High prevalence of postpartum anemia among low-income women in the United States. Am J Obstet Gynecol 2001;185:438-443.
41. Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T. Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol 2002;156:903-912.
42. Bodnar LM, Cogswell ME, Scanlon KS. Low income postpartum women are at risk of iron deficiency. J Nutr 2002; 132:2298-2302.
43. Chen BH, Giudice LC. Dysfunctional uterine bleeding. West J Med 1998;169:280-284.
44. Cohen BJ, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Surv 1980;35:597-618.
45. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:34-37.
46. Weber AM, Lee JC. Use of alternative techniques of hysterectomy in Ohio, 1988-1994. N Engl J Med 1996;335:483-489.
47. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: A systematic review of the literature. Am J Med 2004;116 (Suppl 7A):3S-10S. 48. The Third National Health and Nutrition Examination Survey (NHANES III 1988-1994). National Center for Health Statistics (NCHS), 1994.
48. Patel KV. Epidemiology of anemia in older adults. Semin Hematol 2008;45:210-217.
49. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006;119:327-334.
50. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med 2003;115:104-110.
51. Artz AS. Anemia and the frail elderly. Semin Hematol 2008;45:261-266.
52. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients: A systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-827.
53. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 2004;10: 467-472.
54. Shander A, Cappellini MD, Goodnough LT. Iron overload and toxicity: The hidden risk of multiple blood transfusions. Vox Sang 2009;97:185-197.
55. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. The National Academies Press, 2001.
56. Bothwell TH, Charlton RW. Iron deficiency in women. Washinton, DC: The Nutrition Foundation, 1981.
57. Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: Iron deficiency and iron overload. J Clin Pathol 2011;64:287-296.
58. Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: Molecular basis of iron homoeostasis. J Clin Pathol 2011;64:281-286.
59. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011;106:13-22.
60. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: An overview. J Gen Intern Med 1992;7:145-153.
61. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: A gastroenterological perspective. Dig Dis Sci 2010;55:548-559.
62. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
63. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. Eur J Haematol 1998;60:135-137.
64. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-1057.
65. Choi CW, Cho WR, Park KH, et al. The cutoff value of serum ferritin for the diagnosis of iron deficiency in communityresiding older persons. Ann Hematol 2005;84:358-361.
66. Markovic M, Majkic-Singh N, Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest 2005;65:571-576.
67. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: A systematic review and meta-analysis. Arch Intern Med 2009;169:1104-1112.
68. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol 2002;186:518-522.
69. Alleyne M, Horne MK, Miller JL. Individualized treatment for iron-deficiency anemia in adults. Am J Med 2008;121: 943-948.
70. Fernandez-Gaxiola AC, De-Regil LM. Intermittent iron supplementation for reducing anemia and its associated impairments in menstruating women. Cochrane Database Syst Rev 2011;12:CD009218.
71. De-Regil LM, Jefferds ME, Sylvetsky AC, Dowswell T. Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database Syst Rev 2011;12:CD009085.
72. Shander A, Spence RK, Auerbach M. Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? Transfusion 2010;50:719-732.
73. Auerbach M, Ballard H, Glaspy J. Clinical update: Intravenous iron for anaemia. Lancet 2007;369:1502-1504.
74. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006;21:378-382.
75. Breymann C, Visca E, Huch R, Huch A. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 2001;184:662-667.
76. Breymann C, Richter C, Huttner C, Huch R, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000;30: 154-161.
77. Bennett CL, Silver SM, Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008;299: 914-924.
78. Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL. Iron storage indices: Novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis 2004;38:1090-1094.
79. Auerbach M, Ballard H, Trout JR, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial. J Clin Oncol 2004; 22:1301-1307.